nach oben

Cancer and Metastasis Reviews

Erschienen in:

01.12.2014

Properties and clinical relevance of MTA1 protein in human cancer

verfasst von: Yasushi Toh, Garth L. Nicolson

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Among the genes that were found to be abundantly overexpressed in highly metastatic rat cell lines compared to poorly metastatic cell lines, we identified a completely novel complementary DNA (cDNA) without any homologous or related genes in the database in 1994. The full-length cDNA of this rat gene was cloned, sequenced, and named metastasis-associated gene 1 (mta1), and eventually, its human cDNA counterpart, MTA1, was also cloned and sequenced by our group. MTA1 has now been identified as one of the members of a gene family (MTA gene family) and the products of the MTA genes, the MTA proteins, are transcriptional co-regulators that function in histone deacetylation and nucleosome remodeling and have been found in nuclear histone remodeling complexes. Furthermore, MTA1 along with its protein product MTA1 has been repeatedly and independently reported to be overexpressed in a vast range of human cancers and cancer cell lines compared to non-cancerous tissues and cell lines. The expression levels of MTA1 correlate well with the malignant properties of human cancers, strongly suggesting that MTA1 and possibly other MTA proteins (and their genes) could be a new class of molecular targets for cancer diagnosis and therapy.

Kumar, R., Wang, R. A., & Bagheri-Yarmand, R. (2003). Emerging roles of MTA family members in human cancers. Seminars in Oncology, 30(Suppl 16), 30–37.PubMedCrossRef

Manavathi, B., Singh, K., & Kumar, R. (2007). MTA family of coregulators in nuclear receptor biology and pathology. Nuclear Receptor Signaling, 5, 1–8.CrossRef

Toh, Y., & Nicolson, G. L. (2009). The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clinical and Experimental Metastasis, 26(3), 215–227.PubMedCrossRef

Toh, Y., & Nicolson, G. L. (2011). MTA1 of the MTA (metastasis-associated) gene family and its encoded proteins: molecular and regulatory functions and its role in human cancer progression. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 15(3), 303–315.

Toh, Y., & Nicolson, G. L. (2013). Signaling pathways of MTA family proteins as regulators of cancer progression and metastasis. In R. R. Resende & H. Ulrich (Eds.), Trends in stem cell proliferation and cancer research (pp. 251–275). Dordrecht: Springer.CrossRef

Manavathi, B., & Kumar, R. (2007). Metastasis tumor antigens, an emerging family of multifaceted master coregulators. Journal of Biological Chemistry, 282(3), 1529–1533.PubMedCrossRef

Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature, 408(6810), 377–381.PubMedCrossRef

Moon, H. E., Cheon, H., & Lee, M. S. (2007). Metastasis-associated protein 1 inhibits p53-induced apoptosis. Oncology Reports, 18(5), 1311–1314.PubMed

Moon, H. E., Cheon, H., Chun, K. H., Lee, S. K., Kim, Y. S., Jung, B. K., et al. (2006). Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha. Oncology Reports, 16(4), 929–935.PubMed

10.

Yoo, Y. G., Kong, G., & Lee, M. O. (2006). Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO Journal, 25(6), 1231–1241.PubMedCentralPubMedCrossRef

11.

Li, D. Q., Pakala, S. B., Nair, S. S., Eswaran, J., & Kumar, R. (2012). Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Research, 72(2), 387–394.PubMedCentralPubMedCrossRef

12.

Li, D. Q., & Kumar, R. (2010). Mi-2/NURD complex making inroads into DNA-damage response pathway. Cell Cycle, 9(11), 2071–2079.PubMedCentralPubMedCrossRef

13.

Pakala, S. B., Reddy, S. D., Bui-Nguyen, T. M., Rangparia, S. S., Bommana, A., & Kumar, R. (2010). MTA1 coregulator regulates LPS response via MyD88-dependent signaling. Journal of Biological Chemistry, 285(43), 32787–32792.PubMedCentralPubMedCrossRef

14.

Toh, Y., Pencil, S. D., & Nicolson, G. L. (1994). A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. Journal of Biological Chemistry, 269(37), 22958–22963.PubMed

15.

Nawa, A., Nishimori, K., Lin, P., Maki, Y., Moue, K., Sawada, H., et al. (2000). Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. Journal of Cell Biochemistry, 79(2), 202–212.CrossRef

16.

Toh, Y., Oki, E., Oda, S., Tokunaga, E., Ohno, S., Maehara, Y., et al. (1997). Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. International Journal of Cancer, 74(4), 459–463.CrossRef

17.

Toh, Y., Kuwano, H., Mori, M., Nicolson, G. L., & Sugimachi, K. (1999). Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. British Journal of Cancer, 79(11–12), 1723–1726.PubMedCentralPubMedCrossRef

18.

Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., et al. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biology, 3(1), 30–37.PubMedCrossRef

19.

Toh, Y., Kuninaka, S., Endo, K., Oshiro, T., Ikeda, Y., Nakashima, H., et al. (2000). Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. Journal of Experimental and Clinical Cancer Research, 19(1), 105–111.PubMed

20.

Liu, J., Xu, D., Wang, H., Zhang, Y., Chang, Y., Zhang, J., et al. (2014). The subcellular distribution and function of MTA1 in cancer differentiation. Oncotarget, 5(13), 5153–5164.PubMedCentralPubMed

21.

Aramaki, Y., Ogawa, K., Toh, Y., Ito, T., Akimitsu, N., Hamamoto, H., et al. Direct interaction between metastasis-associated protein 1 and endophilin 3. FEBS Letter, 579(17), 3731–3736

22.

Paterno, G. D., Li, Y., Luchman, H. A., Ryan, P. J., & Gillespie, L. L. (1997). cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein. Journal of Biological Chemistry, 272(41), 25591–25595.PubMedCrossRef

23.

Paterno, G. D., Mercer, F. C., Chayter, J. J., Yan, G. X., Yan, G. X., Robb, J. D., et al. (1998). Molecular cloning of human er1 cDNA and its differential expression in breast tumours and tumour-derived cell lines. Gene, 222(1), 77–82.PubMedCrossRef

24.

Herman, M. A., Ch’ng, Q., Hettenbach, S. M., Ratliff, T. M., Kenyon, C., & Herman, R. K. (1999). EGL-27 is similar to a metastasis-associated factor and controls cell polarity and cell migration in C. elegans. Development, 126(5), 1055–1064.PubMed

25.

Solari, F., Bateman, A., & Ahringer, J. (1999). The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development, 126(11), 2483–2494.PubMed

26.

Kleene, R., Zdzieblo, J., Wege, K., & Kern, H. F. (1999). A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat. Journal of Cell Science, 112(Pt15), 2539–2548.PubMed

27.

Futamura, M., Nishimori, H., Shiratsuchi, T., Saji, S., Nakamura, Y., & Tokino, T. (1999). Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1. Journal of Human Genetics, 44(1), 52–56.PubMedCrossRef

28.

Bowen, N. J., Fujita, N., Kajita, M., & Wade, P. A. (2004). Mi-2/NuRD: multiple complexes for many purposes. Biochimica et Biophysica Acta, 1677(1–3), 52–57.PubMedCrossRef

29.

Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., & Schreiber, S. L. (1998). Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature, 395(6705), 917–921.PubMedCrossRef

30.

Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Cote, J., & Wang, W. (1998). NuRD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Molecular Cell, 2(6), 851–861.PubMedCrossRef

31.

Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999). Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes and Development, 13(15), 1924–1935.PubMedCentralPubMedCrossRef

32.

Wade, P. A., Gegonne, A., Jones, P. L., Ballesta, R. E., Aubry, F., & Wolffe, A. P. (1999). Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nature Genetics, 23(1), 62–66.PubMedCrossRef

33.

Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., & Wade, P. A. (2003). Mta3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell, 113(2), 207–219.PubMedCrossRef

34.

Basta, J., & Rauchman, M. (2014). The nucleosome remodeling and deacetylase complex in development and disease. Translational Research. doi:10.1016/j.trsl.2014.05.003.PubMed

35.

Kelly, T. K., De Carvalho, D. D., & Jones, P. A. (2010). Epigenetic modifications as therapeutic targets. Nature Biotechnology, 28(10), 1069–1078.PubMedCrossRef

36.

Ramirez, J., & Hagman, J. (2009). The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer. Epigenetics, 4(8), 532–536.PubMedCrossRef

37.

Scanlan, M. J., Chen, Y. T., Williamson, B., Gure, A. O., Stockert, E., Gordan, J. D., et al. (1998). Characterization of human colon cancer antigens recognized by autologous antibodies. International Journal of Cancer, 76(5), 652–658.CrossRef

38.

Alqarni, S. S., Murthy, A., Zhang, W., Przewloka, M. R., Silva, A. P., Watson, A. A., et al. (2014). Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplex. Journal of Biological Chemistry, 289(32), 21844–21855.PubMedCentralPubMedCrossRef

39.

Toh, Y., Ohga, T., Endo, K., Adachi, E., Kusumoto, H., Haraguchi, M., et al. (2004). Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. International Journal of Cancer, 110(3), 362–367.CrossRef

40.

Luo, H., Li, H., Yao, N., Hu, L., & He, T. (2014). Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies. Tumour Biology, 35(6), 5823–5832.PubMedCrossRef

41.

Nicolson, G. L., Nawa, A., Toh, Y., Taniguchi, S., Nishimori, K., & Moustafa, A. (2003). Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clinical and Experimental Metastasis, 20(1), 19–24.PubMedCrossRef

42.

Qian, H., Lu, N., Xue, L., Liang, X., Zhang, X., Fu, M., et al. (2005). Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clinical and Experimental Metastasis, 22(8), 653–662.PubMedCrossRef

43.

Qian, H., Yu, J., Li, Y., Wang, H., Song, C., Zhang, X., et al. (2007). RNA interference against metastasis-associated gene 1 inhibited metastasis of B16F10 melanoma cell in c57BL/6 model. Biology of the Cell, 99, 573–581.PubMedCrossRef

44.

Singh, R. R., & Kumar, R. (2007). MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. Journal of Mammary Gland Biology and Neoplasia, 12(2–3), 115–125.PubMedCrossRef

45.

Jang, K. S., Paik, S. S., Chung, H., Oh, Y. H., & Kong, G. (2006). MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Science, 97(5), 374–379.PubMedCrossRef

46.

Martin, M. D., Fischbach, K., Osborne, C. K., Mohsin, S. K., Allred, D. C., & O’Connell, P. (2001). Loss of heterozygosity events impeding breast cancer metastasis contain the mta1 gene. Cancer Research, 61(9), 3578–3580.PubMed

47.

Martin, M. D., Hilsenbeck, S. G., Mohsin, S. K., Hopp, T. A., Clark, G. M., Osborne, C. K., et al. (2006). Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Research and Treatment, 95(1), 7–12.PubMedCrossRef

48.

Sharma, G., Mirza, S., Parshad, R., Srivastava, A., Gupta, S. D., Pandya, P., et al. (2011). Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biology, 32(1), 23–32.PubMedCrossRef

49.

Cheng, C. W., Liu, Y. F., Yu, J. C., Wang, H. W., Ding, S. L., Hsiung, C. N., et al. (2012). Prognostic significance of cyclin D1, beta-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast. Annals of Surgical Oncology, 19(13), 4129–4139.PubMedCrossRef

50.

Mao, X. Y., Chen, H., Wang, H., Wei, J., Liu, C., Zheng, H. C., et al. (2012). MTA1 expression correlates significantly with ER-alpha methylation in breast cancer. Tumour Biology, 33(5), 1565–1572.PubMedCrossRef

51.

Li, S. H., Wang, Z., & Liu, X. Y. (2009). Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer. World Journal of Surgery, 33(9), 1876–1881.PubMedCrossRef

52.

Li, S. H., Tian, H., Yue, W. M., Li, L., Gao, C., Li, W. J., et al. (2012). Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer. World Journal of Surgery, 36(3), 623–631.PubMedCrossRef

53.

Song, L., Wang, Z., & Liu, X. (2013). MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma. Thoracic and Cardiovascular Surgery, 61(6), 479–485.CrossRef

54.

Miyatani, T., Kurita, N., Mikami, C., Kashihara, H., Higashijima, J., Yoshikawa, K., et al. (2011). Malignant potential of Barrett’s esophagus: special reference to HDAC-1 and MTA-1 expression. Hepato-Gastroenterology, 58(106), 472–476.PubMed

55.

Deng, X., Du, L., Wang, C., Yang, Y., Li, J., Liu, H., et al. (2013). Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer. World Journal of Surgery, 37(4), 792–798.PubMedCrossRef

56.

Giannini, R., & Cavallini, A. (2005). Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Research, 25(6B), 4287–4292.PubMed

57.

Du, B., Yang, Z. Y., Zhong, X. Y., Fang, M., Yan, Y. R., Qi, G. L., et al. (2011). Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World Journal of Gastroenterology, 17(9), 1219–1226.PubMedCentralPubMedCrossRef

58.

Higashijima, J., Kurita, N., Miyatani, T., Yoshikawa, K., Morimoto, S., Nishioka, M., et al. (2011). Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer. Oncology Reports, 26(2), 343–348.PubMed

59.

Kidd, M., Modlin, I. M., Mane, S. M., Camp, R. L., Eick, G. N., Latich, I., et al. (2006). Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer, 106(7), 1480–1488.PubMedCrossRef

60.

Kidd, M., Modlin, I. M., Mane, S. M., Camp, R. L., Eick, G., & Latich, I. (2006). The role of genetic markers—NAP1L1, MAGE-D2, and MTA1—in defining small-intestinal carcinoid neoplasia. Annals of Surgical Oncology, 13(2), 253–262.PubMedCrossRef

61.

Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., Eick, G. N., Mane, S. M., et al. (2006). Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Annals of Surgery, 244(1), 52–60.PubMedCentralPubMedCrossRef

62.

Miyake, K., Yoshizumi, T., Imura, S., Sugimoto, K., Batmunkh, E., Kanemura, H., et al. (2008). Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas, 36(3), e1–e9.PubMedCrossRef

63.

Hofer, M. D., Chang, M. C., Hirko, K. A., Rubin, M. A., & Nose, V. (2009). Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors. Modern Pathology, 22(7), 933–939.PubMedCrossRef

64.

Hamatsu, T., Rikimaru, T., Yamashita, Y., Aishima, S., Tanaka, S., Shirabe, K., et al. (2003). The role of MTA1 gene expression in human hepatocellular carcinoma. Oncology Reports, 10(3), 599–604.PubMed

65.

Moon, W. S., Chang, K., & Tarnawski, A. S. (2004). Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-alpha. Human Pathology, 35(4), 424–429.PubMedCrossRef

66.

Ryu, S. H., Chung, Y. H., Lee, H., Kim, J. A., Shin, H. D., Min, H. J., et al. (2008). Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology, 47(3), 929–936.PubMedCrossRef

67.

Lee, S. H., Chung, Y. H., Kim, J. A., Lee, D., Jin, Y. J., Shim, J. H., et al. (2012). Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma. Liver International, 32(3), 457–466.PubMed

68.

Jin, Y. J., Chung, Y. H., Kim, J. A., Park, W. H., Lee, D., Seo, D. D., et al. (2012). Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma. Digestive Diseases and Sciences, 57(11), 2917–2923.PubMedCrossRef

69.

Roepman, P., de Jager, A., Groot Koerkamp, M. J., Kummer, J. A., Slootweg, P. J., & Holstege, F. C. (2006). Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Research, 66(23), 11110–11114.PubMedCrossRef

70.

Kawasaki, G., Yanamoto, S., Yoshitomi, I., Yamada, S., & Mizuno, A. (2008). Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. International Journal of Oral and Maxillofacical Surgery, 37(11), 1039–1046.CrossRef

71.

Li, W. F., Liu, N., Cui, R. X., He, Q. M., Chen, M., Jiang, N., et al. (2012). Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma. Journal of Translational Medicine, 10, 78.PubMedCentralPubMedCrossRef

72.

Deng, Y. F., Zhou, D. N., Ye, C. S., Zeng, L., & Yin, P. (2012). Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: association with metastasis, recurrence, and prognosis. Annals of Otology, Rhinology and Laryngology, 121(7), 457–465.CrossRef

73.

Park, J. O., Jung, C. K., Sun, D. I., Joo, Y. H., & Kim, M. S. (2011). Relationships between metastasis-associated protein (MTA) 1 and lymphatic metastasis in tonsil cancer. European Archives of Otorhinolaryngology, 268(9), 1329–1334.PubMedCrossRef

74.

Sasaki, H., Moriyama, S., Nakashima, Y., Kobayashi, Y., Yukiue, H., Kaji, M., et al. (2002). Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer, 35(2), 149–154.PubMedCrossRef

75.

Zhu, X., Guo, Y., Li, X., Ding, Y., & Chen, L. (2010). Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. Journal of Thoracic Oncology, 5(8), 1159–1166.PubMedCrossRef

76.

Yu, Y., Wang, Z., Zhang, M. Y., Liu, X. Y., & Zhang, H. (2011). Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer. Interactive Cardiovascular and Thoracic Surgery, 12(2), 166–169.PubMedCrossRef

77.

Li, S. H., Tian, H., Yue, W. M., Li, L., Li, W. J., Chen, Z. T., et al. (2011). Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Annals of Surgical Oncology, 18(7), 2048–2056.PubMedCrossRef

78.

Sasaki, H., Yukiue, H., Kobayashi, Y., Nakashima, Y., Kaji, M., Fukai, I., et al. (2001). Expression of the MTA1 mRNA in thymoma patients. Cancer Letter, 174(2), 159–163.CrossRef

79.

Yi, S., Guangqi, H., & Guoli, H. (2003). The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chinese Medical Sciences Journal, 18(2), 87–92.PubMed

80.

Dannenmann, C., Shabani, N., Friese, K., Jeschke, U., Mylonas, I., & Bruning, A. (2008). The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biology and Therapy, 7(9), 1460–1467.PubMedCrossRef

81.

Prisco, M. G., Zannoni, G. F., De Stefano, I., Vellone, V. G., Tortorella, L., Fagotti, A., et al. (2012). Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. Human Pathology, 43(2), 282–288.PubMedCrossRef

82.

Liu, T., Yang, M., Yang, S., Ge, T., Gu, L., & Lou, G. (2013). Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Human Pathology, 44(10), 2275–2281.PubMedCrossRef

83.

Hofer, M. D., Kuefer, R., Varambally, S., Li, H., Ma, J., Shapiro, G. I., et al. (2004). The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Research, 64(3), 825–829.PubMedCrossRef

84.

Dias, S. J., Zhou, X., Ivanovic, M., Gailey, M. P., Dhar, S., Zhang, L., et al. (2013). Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans. Scientific Reports, 3, 2331.PubMedCentralPubMedCrossRef

85.

Hofer, M. D., Tapia, C., Browne, T. J., Mirlacher, M., Sauter, G., & Rubin, M. A. (2006). Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Archives of Pathology and Laboratory Medicine, 130(7), 989–996.PubMed

Titel: Properties and clinical relevance of MTA1 protein in human cancer
verfasst von: Yasushi Toh
Garth L. Nicolson
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 4/2014
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-014-9516-2

Springer Medizin

Properties and clinical relevance of MTA1 protein in human cancer

Abstract

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

E-cadherin germline mutation carriers: clinical management and genetic implications

Significance of MTA1 in the molecular characterization of osteosarcoma

Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy

Biography—Rakesh Kumar, Ph.D.

Molecular functions and significance of the MTA family in hormone-independent cancer

Emerging roles of regulatory T cells in tumour progression and metastasis

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie